Navigation Links
Genstar Capital Appoints Mark Hanson to Managing Director
Date:12/21/2007

Firm's focus On Software & Software Services Yields Two Recent Transactions

SAN FRANCISCO, Dec. 21 /PRNewswire/ -- Genstar Capital, LLC, a middle market private equity firm that focuses on investments in selected segments of life sciences, healthcare services, industrial technology, software and software services, today announced the appointment of Mark Hanson as a Managing Director.

"We have been extremely pleased with Mark's leadership with two significant software and software services transactions since he joined our team one year ago as Operating Partner," said Jean-Pierre L. Conte, Chairman and Managing Director of Genstar. "Mark has extraordinary operational expertise with both large organizations as well as smaller, highly entrepreneurial businesses where he helped to successfully build the operations of a number of companies. We believe his experience and insights in the software industry and his intense operating background will help us to identify additional investment opportunities in what has become a core investment sector for Genstar and create superior returns for our investors."

Mr. Hanson joined Genstar as an Operating Partner in 2006 with more than 24 years of experience in the software industry and leads the firm's investments in Software and Software Services. Prior to joining Genstar, Mr. Hanson served as Senior Vice President for Corporate Development and Chief of Staff for Siebel Systems, Inc., where he worked closely with the executive team to help the company return to growth in 2005. He was responsible for building the M&A function at Siebel and during his tenure the company made 17 acquisitions. Prior to that, he was President and Chief Operating Officer of Visigenic Software, Inc., a company he helped build from a startup entity with no revenues, through its IPO and sale to Borland Software Corporation. He also worked as a senior executive with other leading software companies, including Sybase, Inc., Macromedia, Inc., and Informix Software, Inc. Mr. Hanson is a graduate of Santa Clara University and received his MBA degree from Golden Gate University.

Genstar has completed two acquisitions in 2007 in the software and software services sectors, including the purchase of ConvergeOne, one of the largest independent providers of business communications solutions in the U.S. and TravelCLICK, a leading global provider of interactive distribution solutions and marketing services to independent and chain hotels worldwide.

About Genstar Capital, LLC

Based in San Francisco, Genstar Capital (http://www.gencap.com) is a private equity investment firm that makes leveraged investments in quality middle- market companies. Genstar Capital works in partnership with management to transform its portfolio companies into industry-leading businesses. With more than $3 billion of committed capital under management and significant experience investing in businesses, Genstar focuses on selected segments of life sciences, healthcare services, industrial technology, software and software services.


'/>"/>
SOURCE Genstar Capital, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
2. AtriCure to Present at Roth Capital Partners 2007 New York Conference
3. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
4. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
5. Osteotech to Present at First Albany Capitals Regenerative Technologies Conference in New York
6. iCAD to Present at Americas Growth Capital 4th Annual Emerging Growth Conference
7. Pharsight Files Application for Nasdaq Capital Market Listing
8. Advanced Life Sciences Joins NASDAQ Capital Market
9. Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics
10. Bally Total Fitness Emerges From Chapter 11 and Closes Transaction with Harbinger Capital Partners Funds
11. Caxton-Iseman Capital Acquires Conney Safety Products, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... ... For many years, Andrew G. Zubinas has accumulated over 130 hardcover ... Lithuanian language and its poetry inspired him in writing “ Forest Lungs ... aspects of a living, breathing forest where nothing ever stays the same. His subjects ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... announced today that nominations will be accepted from December 5, 2016 through ... , Awards include the Information Security Executive® of the Year, which recognizes ...
(Date:12/5/2016)... ... December 05, 2016 , ... Worldwise ... global lifestyle design firm kathy ireland® Worldwide for five additional years, announced by ... into an exclusive licensing agreement three years ago to design and develop the ...
(Date:12/5/2016)... ... December 05, 2016 , ... Progressive ... of L-Citrulline and glutathione to enhance production of nitric oxide (NO). , NitroGenesis ... shown to produce NO twice as effectively and sustains NO blood levels twice ...
(Date:12/5/2016)... ... December 05, 2016 , ... ICA, ... alerting technology to Central Illinois Health Information Exchange (CIHIE) using its Smart ... as the sole sub-recipient participating with the Illinois Health Information Exchange Authority ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... According to a new market research report "Cartilage Repair/ ... Tissue Scaffolds, Cell-free composites), Application (Hyaline Cartilage, Fibrocartilage), by Region - ... reach USD 779.8 Million by 2021 from USD 414.6 Million in ... of 2016 to 2021. Continue Reading ... ...
(Date:12/5/2016)... PUNE, India , December 5, 2016 According ... by Product Type and by Application - Global Opportunity Analysis and Industry Forecast, ... 2015, and is expected to reach $5,255 million by 2022, growing at a ... in 2015 with more than four-fifths share. Continue ... ...
(Date:12/5/2016)... and PUNE, India , December ... report by Allied Market Research, titled, "Global Cancer Biomarkers Market ... revenue of cancer biomarkers market is projected to reach $15,737 ... CAGR of 13.3% from 2016 to 2022. Omic technologies segment ... 2015 and is expected to maintain its dominance during the ...
Breaking Medicine Technology: